FDA Approves KYGEVVI®, the First and Only Treatment for Thymidine Kinase 2 deficiency (TK2d)

Science That Changes Lives

From breakthroughs in the lab to real-world progress—accelerating research that delivers results for families today.

Contact Us

For grant-related inquiries, please email grants@mdausa.org.

For all other matters, contact the MDA Resource Center at ResourceCenter@mdausa.org.